Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas

被引:233
|
作者
Jhiang, SM
Sagartz, JE
Tong, Q
ParkerThornburg, J
Capen, CC
Cho, JY
Xing, SH
Ledent, C
机构
[1] OHIO STATE UNIV, CTR BIOTECHNOL, COLUMBUS, OH 43210 USA
[2] UNIV BRUSSELS, FAC MED, INST RECH INTERDISCIPLINAIRE, BRUSSELS, BELGIUM
关键词
D O I
10.1210/en.137.1.375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ret/PTC oncogene, a rearranged form of the ret proto-oncogene, has been found to be restricted to human papillary thyroid carcinomas. This report shows that transgenic mice with thyroid-targeted expression of the ret/PTC1 oncogene developed thyroid carcinomas with considerable similarities to human papillary thyroid carcinomas, particularly in the nuclear cytologic features and the presence of local invasion. Our findings indicate that ret/PTC1 is not only a biomarker associated with papillary thyroid carcinomas, but is also the only proven specific genetic event leading to the development of papillary thyroid carcinoma.
引用
收藏
页码:375 / 378
页数:4
相关论文
共 50 条
  • [21] Different significance of ret/PTC1 and ret/PTC3 rearrangements in thyroid carcinogenesis:: Lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation
    Cetta, F
    Gori, M
    Montalto, G
    Zuckermann, M
    Toti, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03): : 1429 - 1429
  • [22] Prevalence, significance, and biological behavior of ret/PTC1 associated papillary thyroid carcinoma
    Cetta, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05): : 1650 - 1650
  • [23] Temporal trends and clinical correlates for the ret/PTC1 mutation in papillary thyroid carcinoma
    Burgess, JR
    Skabo, S
    McArdle, K
    Tucker, P
    ANZ JOURNAL OF SURGERY, 2003, 73 (1-2) : 31 - 35
  • [24] RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas -: Authors' response
    Learoyd, DL
    Robinson, BG
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06): : 2258 - 2258
  • [25] RET/PTC oncogene expression in papillary thyroid carcinoma and its correlation with clinicopathologic findings
    Arpaci, Dilek
    Uzum, Ayse Kubat
    Kapran, Yersu
    Ozbey, Nese Colak
    ENDOCRINOLOGIST, 2008, 18 (05): : 233 - +
  • [26] Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors
    De Vita, G
    Zannini, M
    Cirafici, AM
    Melillo, RM
    Di Lauro, R
    Fusco, A
    Santoro, M
    CELL GROWTH & DIFFERENTIATION, 1998, 9 (01): : 97 - 103
  • [27] Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene
    Monaco, Mario
    Palma, Giuseppe
    Vitiello, Michela
    Capiluongo, Anna
    D'Andrea, Barbara
    Vuttariello, Emilia
    Luciano, Antonio
    Cerchia, Laura
    Chiappetta, Gennaro
    Arra, Claudio
    Fusco, Alfredo
    Fedele, Monica
    CANCERS, 2018, 10 (04)
  • [28] RET/PTC1 in vitro models unveil a novel tumor suppressor miRNA in papillary thyroid carcinoma
    Minna, E.
    Romeo, P.
    De Cecco, L.
    Dugo, M.
    Cassinelli, G.
    Lanzi, C.
    Pilotti, S.
    Pierotti, M. A.
    Greco, A.
    Borrello, M. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S31 - S31
  • [29] Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma
    Rhoden, KJ
    Johnson, C
    Brandao, G
    Howe, JG
    Smith, BR
    Tallini, G
    LABORATORY INVESTIGATION, 2004, 84 (12) : 1557 - 1570
  • [30] Expression of wild type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany
    Mayr, B
    Pötter, E
    Goretzki, P
    Rüschoff, J
    Dietmaier, W
    Hoang-Vu, C
    Dralle, H
    Brabant, G
    LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (01) : 54 - 59